Michael Ulz
Stock Analyst at Morgan Stanley
(3.68)
# 2,073
Out of 4,463 analysts
557
Total ratings
47.3%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 | $301.03 | +22.91% | 45 | Jun 29, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $100 | $81.51 | +22.68% | 25 | Jun 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $130 | $79.29 | +63.96% | 36 | Jun 24, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $95 | $39.01 | +143.53% | 24 | Jun 24, 2026 | |
| BIOA BioAge Labs | Maintained: Hold | $23 | $24.51 | -6.16% | 14 | Jun 16, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $150 | $117.07 | +28.13% | 24 | Jun 15, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $136 | $111.03 | +22.49% | 20 | Jun 14, 2026 | |
| VIR Vir Biotechnology | Rated: Buy | $23 → $27 | $10.19 | +164.97% | 23 | Jun 11, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | $25 | $10.98 | +127.69% | 33 | Jun 11, 2026 | |
| GUTS Fractyl Health | Maintained: Hold | $2 | $0.7944 | +151.76% | 16 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $3.11 | +318.01% | 21 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $22.21 | +111.62% | 24 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7391 | +170.60% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $8.91 | +270.37% | 22 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $3 | $5.76 | -47.92% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.85 | -17.53% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.42 | +46.20% | 17 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 → $25 | $17.97 | +39.12% | 28 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.0061 | +5,801.64% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $9.58 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.70 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $16.33 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.5 | $4.07 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.77 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.10 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $29.98 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $4.16 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $6.81 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $3 | $34.38 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $57.22 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.40 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.39 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.45 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.27 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $927.77 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $60 | $6.72 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.26 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $21.86 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.6123 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $10.83 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $8 | $0.000001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $40 | $3.82 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.13 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $126.34 | n/a | 1 | May 18, 2010 |
Alnylam Pharmaceuticals
Jun 29, 2026
Maintained: Hold
Price Target: $370
Current: $301.03
Upside: +22.91%
Arrowhead Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $100
Current: $81.51
Upside: +22.68%
Ionis Pharmaceuticals
Jun 24, 2026
Reiterated: Buy
Price Target: $130
Current: $79.29
Upside: +63.96%
Viking Therapeutics
Jun 24, 2026
Maintained: Buy
Price Target: $95
Current: $39.01
Upside: +143.53%
BioAge Labs
Jun 16, 2026
Maintained: Hold
Price Target: $23
Current: $24.51
Upside: -6.16%
Mirum Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $150
Current: $117.07
Upside: +28.13%
Rhythm Pharmaceuticals
Jun 14, 2026
Reiterated: Buy
Price Target: $136
Current: $111.03
Upside: +22.49%
Vir Biotechnology
Jun 11, 2026
Rated: Buy
Price Target: $23 → $27
Current: $10.19
Upside: +164.97%
Silence Therapeutics
Jun 11, 2026
Reiterated: Buy
Price Target: $25
Current: $10.98
Upside: +127.69%
Fractyl Health
Jun 4, 2026
Maintained: Hold
Price Target: $2
Current: $0.7944
Upside: +151.76%
Jun 3, 2026
Maintained: Buy
Price Target: $13
Current: $3.11
Upside: +318.01%
Jun 3, 2026
Reiterated: Buy
Price Target: $47
Current: $22.21
Upside: +111.62%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7391
Upside: +170.60%
Jun 3, 2026
Maintained: Buy
Price Target: $33
Current: $8.91
Upside: +270.37%
May 15, 2026
Downgraded: Sell
Price Target: $7 → $3
Current: $5.76
Upside: -47.92%
May 13, 2026
Maintained: Hold
Price Target: $4
Current: $4.85
Upside: -17.53%
Mar 27, 2026
Maintained: Hold
Price Target: $5
Current: $3.42
Upside: +46.20%
Mar 26, 2026
Rated: Hold
Price Target: $20 → $25
Current: $17.97
Upside: +39.12%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.0061
Upside: +5,801.64%
Mar 11, 2025
Maintained: Buy
Price Target: $5
Current: $9.58
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5
Current: $2.70
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $16.33
Upside: n/a
Aug 13, 2024
Maintained: Sell
Price Target: $0.5
Current: $4.07
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $9.77
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $1.10
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $40
Current: $29.98
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $4.16
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $6.81
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7 → $3
Current: $34.38
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $57.22
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.40
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $33.39
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $31.45
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $37.27
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $340
Current: $927.77
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $69 → $60
Current: $6.72
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $24.26
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $37
Current: $21.86
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $5
Current: $0.6123
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $10.83
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: $15 → $8
Current: $0.000001
Upside: n/a
Mar 28, 2019
Maintained: Hold
Price Target: $3 → $40
Current: $3.82
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $6.13
Upside: n/a
May 18, 2010
Maintained: Buy
Price Target: $28
Current: $126.34
Upside: n/a